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Staphylococcus epidermidis is an important cause of nosocomial infections. Virulence is attributable to
elaboration of biofilms on medical surfaces that protect the organisms from immune system clearance. Even
though leukocytes can penetrate biofilms, they fail to phagocytose and kill bacteria. The properties that make
biofilm bacteria resistant to the immune system are not well characterized. In order to better understand the
mechanisms of resistance of bacteria in biofilms to the immune system, we evaluated antibody penetration
throughout the biofilm and antibody-mediated phagocytic killing of planktonic versus biofilm cells of S.
epidermidis by using a rabbit antibody to poly-N-acetylglucosamine (PNAG). These antibodies are opsonic and
protect against infection with planktonic cells of PNAG-positive Staphylococcus aureus and S. epidermidis.
Antibody to PNAG readily penetrated the biofilm and bound to the same areas in the biofilm as did wheat germ
agglutinin, a lectin known to bind to components of staphylococcal biofilms. However, biofilm cells were more
resistant to opsonic killing than their planktonic counterparts in spite of producing more PNAG per cell than
planktonic cells. Biofilm extracts inhibited opsonic killing mediated by antibody to PNAG, suggesting that the
PNAG antigen within the biofilm matrix prevents antibody binding close to the bacterial cell surface, which is
needed for efficient opsonic killing. Increased resistance of biofilm cells to opsonic killing mediated by an
otherwise protective antibody was due not to a biofilm-specific phenotype but rather to high levels of antigen
within the biofilm that prevented bacterial opsonization by the antibody.
Staphylococcus epidermidis and other coagulase-negative
staphylococci are among the most frequent causes of nosoco-
mial infections (29, 41) and are often associated with the use of
medical devices (38). A critical virulence determinant in such
infections is the ability to form biofilms on synthetic materials
(3). The biofilm matrix of S. epidermidis is composed mainly of
a large exopolysaccharide, poly-N-acetylglucosamine (PNAG)
(31), which is involved in intercellular adhesion and is some-
times referred to as polysaccharide intercellular adhesin (21).
Opsonic antibody to PNAG mediates protection against sys-
temic infection by both S. epidermidis (16, 35) (where it was
called capsular polysaccharide/adhesin) and Staphylococcus
aureus (23). However, the ability of antibody to this antigen to
interact with staphylococcal cells within a biofilm has not been
investigated. As staphylococcal infections, particularly those
associated with indwelling medical devices, are not only diffi-
cult to treat and eradicate but also associated with high rates of
relapse infection (4, 9), it is possible that even if the host
mounts an immune response to protective staphylococcal an-
tigens like PNAG, as has recently been shown to occur in S.
aureus-infected cystic fibrosis patients (14), these antibodies
may not effectively kill bacterial cells within a biofilm.
PNAG is synthesized by proteins encoded by the icaADCB
locus (10, 24) and has several described functions: it acts as an
intercellular adhesin promoting cell-to-cell aggregation (7, 10),
and it is responsible for biofilm maturation (38). PNAG also
plays a crucial role in the protection of planktonic S. aureus
and S. epidermidis cells from antibody-independent phagocy-
tosis (17, 34, 37). However, despite these findings, the role of
PNAG in the resistance of bacterial cells embedded within a
biofilm to host opsonic killing mechanisms, particularly in the
presence of a potentially opsonic and protective antibody, has
not been reported.
When bacteria assume the biofilm phenotype, they display
several properties that differ from those expressed during
planktonic growth (1, 40), including enhanced resistance to
antimicrobials (11) and differential gene expression (30). Bio-
films also protect the resident bacteria from attack by phago-
cytes and complement (8, 36). A previous study (13) has shown
that opsonic antibodies to Pseudomonas aeruginosa alginate
can mediate killing of the alginate-overexpressing mucoid phe-
notype of this organism when grown as a biofilm, while another
study using nonmucoid P. aeruginosa strain PAO1 biofilms
showed that neutrophils could phagocytose planktonic bacteria
released from the biofilm but that this made them less active
against the bacterial cells within the biofilm (13). Leid et al.
have shown that human leukocytes can easily penetrate S.
aureus biofilms but fail to phagocytose the bacteria (19).
In order to determine the effect of the biofilm growth on the
activity of an opsonic, protective antibody to S. epidermidis, we
evaluated the ability of a rabbit immunoglobulin raised against
PNAG to penetrate into S. epidermidis biofilms and to mediate
opsonic killing. Antiserum with specificity for this antigen was
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chosen, as previous work has shown that normal sera contain
antibodies to other S. epidermidis antigens but that these nor-
mal sera fail to mediate opsonic killing or protective immunity
to S. epidermidis strains that express PNAG (16, 35). PNAG-
producing S. epidermidis strains constitute a large majority of
clinical isolates (27, 43). Also, during experimental infection in
rabbits, S. epidermidis provokes immune responses to multiple
cell wall antigens, but again, these fail to mediate in vitro
opsonic killing or reduce levels of infections in tissues once
elicited following infection (33, 34). Importantly, antibody-
mediated opsonic killing specific to the PNAG antigen is the
only well-defined antigen-antibody system which has demon-
strated protection against S. epidermidis infection in animal
infections and thus represents a host-microbe interaction that
can be analyzed to explore mechanisms of resistance of biofilm
cells to mediators of immunity.
In the present study, we found that the biofilm did not pose
an overall diffusion barrier to the antibody, but when we com-
pared the opsonophagocytic killing of planktonic and biofilm
cells of four S. epidermidis strains, there was a distinct differ-
ence between the susceptibilities of planktonic and biofilm-
grown cells to phagocytic killing. We found greatly enhanced
PNAG production by the biofilm cells, suggesting that the
excess antigen inhibited the antibody-mediated phagocytosis of
the biofilm bacteria by preventing the deposition of quantities
of antibody on the bacterial cell surface sufficient to mediate
high levels of phagocytic killing.
MATERIALS AND METHODS
Growth conditions. All S. epidermidis strains were grown at 37°C on tryptic soy
agar plates. Liquid cultures were grown overnight in tryptic soy broth (TSB)
supplemented with an additional 1% glucose (TSBG) at 37°C and with shaking
at 200 rpm.
Bacterial strains and analysis of PNAG production. In this study, nine distinct
S. epidermidis strains isolated from infective endocarditis, dialysis-associated
peritonitis, and blood were used (3), as were two control strains kindly provided
by Dietrich Mack, Sansea, Wales, United Kingdom: S. epidermidis 9142, a
strongly biofilm-producing strain, and S. epidermidis 9142-M10, which has a
transposon in the icaADCB locus and does not form a biofilm (21). All strains
were first characterized in terms of the presence of the ica operon by extracting
genomic DNA and performing a PCR for the presence of the icaC gene with the
following primers: 5-ATAGTGAATCACTTATCACCGC-3 and 5-GAGAAT
CTAAGATAATTGGGTGC-3. PNAG production and detection by immuno-
blotting were performed essentially as described by Cramton et al. (6). Biofilms
were grown in 96-well polystyrene plates in TSBG and quantified as described by
Heilmann et al. (10). We then selected the strains that were ica-positive strong
PNAG producers that formed thick biofilms to use in the opsonophagocytic
assays.
Opsonophagocytosis of planktonic and biofilm bacteria by serum raised to
PNAG. To prepare bacteria for evaluation of susceptibility to opsonic killing,
biofilms were formed in six-well polystyrene plates (Sarsted, Germany) by grow-
ing cells at 37°C in TSBG for 24 h with a constant rocking motion. Biofilms were
fragmented by scraping cells from the plastic surface and sonicating twice for 5 s
at 20 W (VC600; Sonics, Newtown, CT) to homogenize the suspension. Plank-
tonic bacteria were grown overnight in TSBG at 37°C with shaking and were
sonicated as described above. Both suspensions were then diluted in TSBG to a
concentration of approximately 2  108 cells/ml as determined by the optical
density at 640 nm. The opsonophagocytic assay was performed as described by
Maira-Litra´n et al. (22) using a rabbit polyclonal serum raised against deacety-
lated PNAG conjugated to diphtheria toxoid (23) with a final bacterial cell
concentration of approximately 1  107 cells/ml. Briefly, the opsonophagocytic
assay mixture contained 100 l of leukocytes (at a concentration of 2  107
cells/ml), 100 l of a bacterial suspension at 1  107 cells/ml, 100 l of a 1:15
dilution of infant rabbit serum as a complement source, and 100 l of the
antibody diluted 1:10. All components were suspended or diluted in RPMI
medium with 15% heat-inactivated fetal bovine serum. Control tubes consisted
of assay mixtures wherein one of the essential components (phagocytes, com-
plement, or antibody) was individually replaced with 100 l of RPMI-fetal bovine
serum. The reaction mixture was incubated on a rotor rack at 37°C for 90 min.
The tubes were vortexed for 15 s, and samples were diluted in TSB with 0.05%
Tween to prevent bacterial aggregation and adherence to the walls of the dilution
vessel and plated onto tryptic soy agar plates. The percentage of killing was
calculated by determining the ratio of the CFU surviving in the tubes with
bacteria, leukocytes, complement, and antibody to the CFU surviving in the
control tubes. Each condition was evaluated in triplicate, and each assay was
repeated two to three times.
CSLM analysis. Biofilms were prepared for confocal scanning laser micros-
copy (CSLM) analysis as previously described (28), with some modifications.
Briefly, biofilms formed on six-well polystyrene plates as described above were
washed twice with 0.9% NaCl. The biofilms were incubated for 2 h at room
temperature with affinity-purified rabbit immunoglobulin G (IgG) antibody (14)
specific to S. aureus PNAG (23) and washed three times for 5 min each with
phosphate-buffered saline (PBS). The secondary antibody used was an Alexa
488-conjugated goat anti-rabbit IgG (Molecular Probes) at 2 mg/liter; biofilms
were incubated with it for 1 h at room temperature in the dark and then washed
three times for 5 min each with PBS. Some of the biofilms were also incubated
with wheat germ agglutinin (WGA) conjugated to Texas Red (Molecular Probes)
at 10 mg/liter for 20 min at room temperature in the dark. After staining, the
biofilms were gently rinsed with PBS.
Confocal scanning laser microscopy analysis was performed with an LSM 510
Meta (Zeiss, Germany) attached to an Axioplan II microscope (Zeiss, Ger-
many), as previously described (18) with some modifications. Biofilms formed by
S. epidermidis strain 9142 were observed using a 63 water immersion objective
(Achroplan 63/0.95W) with a multiple-track channel analysis. The first-channel
excitation wavelength was set at 633 nm, with output power of 70%, and bacterial
cells were detected as refracted light. A second channel, with an excitation
wavelength of 488 nm and output power of 10%, was used to detect where the
antibodies had bound. A third channel, with an excitation wavelength of 543 nm
and output power of 70%, was used to detect where WGA had bound. The
excitation beam splitter used was HFT UV/488/543/633. The filters used to detect
the refracted light by the biofilm cells were NFT 635 VIS and BP 500-550 for the
antibodies and LP650 for the WGA. The beam splitter used was NFT 545.
Relative quantification of PNAG in planktonic and biofilm cells and super-
natants. For relative evaluation of the concentration of PNAG in biofilms and in
planktonic cells, we selected biofilms and planktonic cells of S. epidermidis strain
9142. Biofilms were scraped and sonicated as described above, and then bacterial
cells from both planktonic and biofilm cultures were adjusted to a concentration
of 109 cells/ml. PNAG was extracted using EDTA and heat and detected by
immunoblotting as described by Cramton et al. (6). For detection of PNAG in
the supernatants, an aliquot of growth medium from biofilm or planktonic cells
equivalent to the volume in which 109 CFU were present was centrifuged at
10,500  g for 10 min and filter sterilized, and the contents in the entire aliquot
were immobilized on a membrane and then probed for PNAG by immunoblot-
ting (6).
Inhibition of phagocytosis by the biofilm matrix and purified PNAG. Inhibi-
tion of phagocytosis was evaluated as described by Maira-Litra´n et al. (23), with
some modifications. To obtain soluble components of the biofilm matrix formed
after 24 h of growth, a biofilm culture of S. epidermidis strain 9142 was released
from the solid matrix by sonication in TSB, diluted in TSB to a concentration of
approximately 1  109 cells/ml, and centrifuged at 10,500  g for 10 min. The
supernatant was boiled in EDTA for 5 min to facilitate solubilization of the
PNAG (6) and then allowed to cool down to room temperature. For each
milliliter of supernatant, 20 l of proteinase K (20 mg/ml; QIAGEN) was added,
and the supernatant was then incubated for 60 min at 60°C. The proteinase K was
heat inactivated for 30 min at 80°C. We also used a solution of 100 mg/liter of
purified PNAG that was kindly provided by T. Maira-Litra´n, Boston, MA (22),
as a positive control. As a negative control, a culture of S. epidermidis 9142-M10
grown for 24 h was diluted to approximately 1  109 cells/ml and treated with
EDTA to extract surface polysaccharides, as described previously (2). A rabbit
polyclonal antiserum raised against the deacetylated PNAG conjugated to diph-
theria toxoid (23) was diluted 1:5, and the antiserum was incubated for 90 min at
4°C with an equal volume of either the biofilm matrix extract, a solution of 100
mg/liter of PNAG, the cell surface extract of 9142-M10, or TSB. Subsequently,
the antiserum was centrifuged and filtered, and the absorbed serum was used in
an opsonophagocytic assay as described above.
Statistical analysis. Analysis of the statistical significance between pairs of
data for which the comparisons of interest were specified prior to looking at the
results were conducted with a t test. Analysis of variance (ANOVA) was used for
determining differences among multiple groups.
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RESULTS
Characterization of S. epidermidis isolates. Table 1 summa-
rizes the relative levels of PNAG in and amounts of biofilm
formed by, as well as the presence of the icaC gene in, the S.
epidermidis strains used in this study. The positive control, S.
epidermidis 9142, was icaC positive, exhibited high levels of
PNAG production, and formed a thick biofilm. The negative
control, S. epidermidis 9142-M10, was not able to form biofilm
or to produce PNAG, as expected (21). Most of the clinical
isolates of S. epidermidis had the icaC gene (six out of nine).
However, only three clinical isolates were strong PNAG pro-
ducers, and these were also the three strains that formed thick
biofilms. Accordingly, these three clinical isolates (IE186,
IE214, and M187) and also the positive control strain 9142
were selected to perform the phagocytic assays.
Antibody penetration into the biofilm. To determine
whether the three-dimensional structure of the biofilm acted as
a physical barrier to the penetration of antibody, we allowed
PNAG-specific rabbit antibodies to bind to biofilms formed by
S. epidermidis strain 9142, which were then observed by CSLM.
This confocal microscopic analysis of the mixture revealed that
the antibodies were able to penetrate throughout the biofilm,
as visualized in the x and y cross sections of the biofilm (Fig. 1),
demonstrating that S. epidermidis biofilms do not pose a per-
meability barrier to antibodies. Prior work measuring the dif-
fusion of small molecules through PNAG-based biofilms of S.
aureus also showed that there was easy penetration of these
molecules throughout the biofilm (12). S. epidermidis biofilms
reached thicknesses of approximately 100 m (2).
Localization of the antibody in the biofilm matrix. Wheat
germ agglutinin has been shown to bind to the biofilm matrix
of S. epidermidis (28), possibly due to its ability to recognize
the N-acetylglucosamine component of the PNAG antigen,
although it may recognize other components, such as pep-
tidoglycan and teichoic acid, which also contain glucosamine
and form part of the biofilm matrix. We sought to determine
if the antibody to PNAG bound to the same areas of the
biofilm as did WGA. Figure 2 is a top view of a biofilm,
representing the results obtained using three distinct con-
focal microscope channels: Fig. 2A shows the binding of the
antibody to PNAG, Fig. 2B shows the biofilm matrix visu-
alized as a result of the lectin binding, and Fig. 2C shows the
three-dimensional structure of the biofilm. Figure 2D shows
the overlap of the signals from all of the channels. It could
be seen that a fair amount of the antibody signal (green)
overlapped with the lectin signal (red) as indicated by the
yellow color that appears in Fig. 2D, suggesting that a large
proportion of the antibody is sequestered within the biofilm
matrix rather than closely associated with the bacterial cells.
Although it appears from this top view in Fig. 2 that the
FIG. 1. Analysis of the ability of rabbit IgG antibodies to PNAG to penetrate into a biofilm formed by S. epidermidis strain 9142; the x axis
(upper panel) and y axis (lower panel) cross sections of the biofilm are shown. Rabbit antibody to PNAG was visualized using goat anti-rabbit IgG
conjugated to Alexa 488.
TABLE 1. Characterization of the S. epidermidis
strains used in this study
Strain ica locusa,b PNAGblotb
Biofilm
formationb
S. epidermidis 9142   
S. epidermidis 9142-M10   
S. epidermidis IE75   
S. epidermidis IE186   
S. epidermidis IE214   
S. epidermidis M129   
S. epidermidis M187   
S. epidermidis FJ6   
S. epidermidis JI6   
S. epidermidis LE7   
S. epidermidis PE9   
a Detected with primers for the icaC gene within the icaADCB locus.
b A  indicates that the icaC gene was present, a strong PNAG immunoblot
signal was produced, or a biofilm was produced. A indicates that the icaC gene
locus was absent, the PNAG immunoblot signal produced was weak or absent, or
no biofilm was produced.
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smaller lectin molecule (36 kDa) might have penetrated the
biofilm somewhat better than the 150-kDa antibody mole-
cules, the x and y cross sections shown in Fig. 1 show that the
antibody can readily penetrate throughout the biofilm in
both the vertical and horizontal planes.
Opsonophagocytosis of planktonic and biofilm cells. Figure 3
illustrates the antibody-mediated phagocytic killing of suspen-
sions of planktonic and disrupted biofilm cells of S. epidermidis.
It is clear that planktonic cells were more easily killed in the
phagocytic assay than were the biofilm cells. The average kill-
ing of the planktonic cell suspensions was 60%, while in
biofilm cells, even as fragments in suspension, the average
percentage of phagocytic killing dropped to less than 20% (P
0.05, paired t tests for comparisons between each pair of bio-
film and planktonic cells). The levels of killing of planktonic
cells of S. epidermidis were similar to previous reports for
opsonic killing of S. aureus and S. epidermidis planktonic cells
using antibody to PNAG (22, 23). When tested by ANOVA for
homogeneity of the killing activity within groups, there were no
significant differences in the killing of the four strains as plank-
tonic cells and no significant differences in the killing of the
four strains in the biofilm state.
Relative quantification of PNAG in planktonic and biofilm
cells. To compare the amounts of PNAG that were secreted or
cell surface associated in biofilm and planktonic cells, cell
culture supernatants or suspensions of disrupted biofilms and
planktonic cells of S. epidermidis strain 9142 with 109 cells/ml
were extracted with EDTA and heat and were analyzed. Figure
4 presents the relative quantification of PNAG in these sam-
ples as determined by immunoblotting. In both the biofilm and
planktonic cells, the PNAG was largely cell surface associated
(Fig. 4, lanes 2 and 4), with approximately 100-fold more
PNAG on the surface than in the culture supernatant. PNAG
was also more abundant on biofilm cells (10-fold more) than
planktonic cells, and this difference was even more pronounced
for the secreted polysaccharide (10-fold more PNAG in su-
pernatants from biofilm cells than in supernatants from plank-
tonic cells).
Inhibition of phagocytosis by PNAG from the biofilm ma-
trix. To determine if biofilms could produce sufficient PNAG
FIG. 2. Analysis of binding of either rabbit IgG to PNAG or WGA to components of the biofilm formed by S. epidermidis strain 9142. The
following Z sections are shown: panel A, binding of rabbit IgG to PNAG visualized by a goat antibody to rabbit IgG conjugated to Alexa 488; panel
B, WGA directly conjugated to Texas Red; panel C, overall biofilm structure as visualized by the refraction of far red light; panel D, colocalization
of binding of antibody to PNAG and WGA. In panel D, the antibody signal is shown in green and the lectin signal is shown in red, with the overlap
causing the yellow color.
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to inhibit phagocytosis, the biofilm matrix formed by S. epider-
midis strain 9142 was extracted and used in an opsonic killing
inhibition assay. As a positive control, purified PNAG (50
mg/liter) was also used in the inhibition assay, and as a negative
control, a comparably prepared cell surface extract of strain
9142-M10 was used. Figure 5 demonstrates that addition of
either undiluted or 1:10 diluted S. epidermidis 9142 biofilm
matrix components to antibodies to PNAG markedly de-
creased the opsonic killing of planktonic cells. While nonin-
hibited antibodies (simply diluted in fresh medium) killed
60% of the planktonic bacteria (comparable to results shown
in Fig. 3), after incubation of the antibodies to PNAG with
either undiluted or 1:10 diluted biofilm matrix there was a
75% inhibition of killing of an equivalent suspension of
planktonic bacteria. PNAG at 50 mg/liter inhibited 90% of
the killing, whereas the cell surface extract of strain 9142-M10
did not inhibit the opsonic killing. These results suggest that
there is a sufficient amount of the PNAG component in the
biofilm matrix that can bind to the opsonic antibodies to sub-
sequently inhibit the killing of otherwise susceptible bacteria.
DISCUSSION
In the last few years, several studies reporting the increased
resistance of biofilms to killing by components of the immune
system were published (13, 15, 25, 42). However, it is still not
clear if this resistance is associated with bacterial phenotypic
alterations triggered by the sessile mode of life. A better un-
derstanding of mechanisms whereby cells in biofilms resist
killing by the immune system is needed, as suggested by Leid et
al. in their recent study on polymorphonuclear leukocyte pen-
etration into P. aeruginosa biofilms (20).
While it is well known that bacteria have a number of mech-
anisms by which they evade immune defenses, such as capsule
synthesis (26, 32), surface protein modification, and molecular
mimicry, it is not clear how these factors might contribute to
biofilm-specific properties that confer resistance to clearance
by the immune system. Furthermore, studies comparing the
susceptibilities of planktonic and biofilm cells to antibodies
established to be opsonic and protective against infection with
planktonic cells have been limited (13). Here we found that S.
epidermidis cells within the biofilm matrix were more resistant
to opsonic killing mediated by antibody to PNAG than plank-
tonic cells. However, the well-known increase in synthesis of
PNAG associated with the formation of biofilms by S. epider-
midis did not establish a barrier to antibody diffusion through-
out the biofilm, which indicates that this potential mechanism
of resistance to opsonic killing was unlikely to account for the
reduced killing of cells. Rather, the increased production of
PNAG within the biofilm appeared to overwhelm the antibody
added and was able to inhibit killing of planktonic cells when
the biofilm matrix was mixed with antibody prior to use in a
phagocytosis assay. Whether this mechanism of biofilm cell
resistance to phagocytosis is used for other antigenic targets is
not known, but to date no other clearly characterized antigenic
FIG. 3. Opsonophagocytic killing of different S. epidermidis stains
grown either in the planktonic (P) or biofilm (B) mode. Killing was
determined using a 1:10 dilution of rabbit antibody raised to deacety-
lated PNAG conjugated to diphtheria toxoid, and the percent killing
was calculated using the mean CFU in duplicate determinations from
three different control tubes lacking one of the assay components as
the denominator. Killing in the presence of normal rabbit serum was
always 5%. There were no significant differences in killing achieved
when comparing all four strains grown as planktonic cells and no
significant differences in killing when comparing all four strains grown
as biofilm cells (P  0.1; ANOVA). There were significant differences
in killing for each strain when comparing planktonic versus biofilm
cells at P  0.05 (unpaired samples t test).
FIG. 4. Expression of PNAG in culture supernatants and cell sur-
face extracts of S. epidermidis strain 9142. Dilutions of each sample are
indicated on the top of the figure. Row 1, supernatant from planktonic
cells; row 2, EDTA extract of planktonic cells; row 3, supernatant of
biofilm cells; row 4, EDTA cell extract of biofilm cells.
FIG. 5. Inhibition of opsonic killing of planktonic cells of S. epider-
midis strain 9142. A rabbit antiserum to deacetylated PNAG (diluted
1:10) was adsorbed with either TSB, strain 9142 biofilm matrix (undi-
luted or diluted 1:10), strain 9142-M10 cell surface extract, or purified
PNAG before use in the opsonophagocytic assay. The reduction in
percent killing by both the biofilm matrix (undiluted and at 1:10 dilu-
tions) and 50 mg/liter PNAG was significant at P  0.05 (t test) when
compared with the TSB-inhibited sample.
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target of opsonic and protective antibody has been described
for PNAG-producing S. epidermidis.
Phagocytic assays have been widely used to test for resis-
tance of bacteria to components of the immune system (32, 37,
39). However, application of this technique to biofilms poses
some serious technical limitations. The assay is functional only
with a low number of bacterial cells (normally about 107
CFU/ml in order to maintain a balanced proportion of bacteria
and leukocytes), and mature biofilms have a much higher cell
density. In order to compare biofilm with planktonic bacteria
phagocytosis, we disrupted the biofilm and diluted the suspen-
sion until a lower bacterial cell concentration, the same as that
used for planktonic bacteria, was reached, as described previ-
ously by Meluleni et al. (25). Although it can be questioned
whether disrupted biofilms are representative of cells within a
native three-dimensional biofilm, fragmented biofilms do have
the same physiological state as do cells within a mature biofilm
(38), and this physiologic state is thought to be a possible
reason that some infections are resistant to host immune ef-
fectors (5). In addition, it is not clear whether the biofilms
formed under optimal in vitro conditions are true mimics of
those formed on infected medical devices, which in most in-
fections are unlikely to be as extensively covered with cells and
components of the biofilm matrixes as can be achieved by
growth in vitro in tissue culture wells. Thus, analyzing smaller
fragments of biofilms in our assays likely has some relevance to
biofilms formed in vivo.
Overall, the results presented here show that the biofilm
matrix can protect bacteria from antibody-mediated phagocy-
tosis in the presence of an antibody opsonically active against
planktonic cells, probably due to the large amount of PNAG
antigen present within the matrix. This situation minimizes
antibody binding close to the bacterial cell surface, where it
needs to be in order to promote opsonic killing. We also found
much more PNAG produced per cell within the biofilm matrix,
supporting the conclusion that this large amount of antigen can
inhibit antibody binding to the bacterial cell surface. While
PNAG is known to protect planktonic bacteria against anti-
body-independent phagocytosis (17, 39), it appears that even in
the presence of opsonic antibody to PNAG the excess produc-
tion of the target antigen within the biofilm can prevent effi-
cient opsonic killing. It does not appear that the resistance to
opsonic killing is due to poor penetration of antibody, comple-
ment, or phagocytes into the biofilm, as some residual killing
was always seen; this indicates that if the proper combination
of opsonins and phagocytes in sufficient concentration can be
achieved within a biofilm, opsonic antibody may also have
some protective effects in this setting. However, whether the
concentrations of antibody needed to overcome this inhibitory
effect can be feasibly achieved in vivo is not known.
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